CN102106937A - Medicament for treating psoriasis - Google Patents

Medicament for treating psoriasis Download PDF

Info

Publication number
CN102106937A
CN102106937A CN2011100434628A CN201110043462A CN102106937A CN 102106937 A CN102106937 A CN 102106937A CN 2011100434628 A CN2011100434628 A CN 2011100434628A CN 201110043462 A CN201110043462 A CN 201110043462A CN 102106937 A CN102106937 A CN 102106937A
Authority
CN
China
Prior art keywords
radix
medicament
medicine
root
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011100434628A
Other languages
Chinese (zh)
Other versions
CN102106937B (en
Inventor
徐海彬
郝战旗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011100434628A priority Critical patent/CN102106937B/en
Publication of CN102106937A publication Critical patent/CN102106937A/en
Application granted granted Critical
Publication of CN102106937B publication Critical patent/CN102106937B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating psoriasis, which is prepared by the steps of uniformly mixing raw radix rehmanniae, Chinese angelica, szechuan lovage rhizome, white paeony root, honeysuckle, red paeony root, red flower, peach seed, periostracum cicadae, lightyellow sophora root, white ringworm skin, isatis root, common ducksmeat herb, sophora flower, cornu bubali, turtle shell, tortoise plastron, long-noded pit viper and tail snake; crushing the medicines into medicinal powder of 100-120 meshes; and according to a conventional method, adding honey to the medicinal powder, forming, sterilizing and disinfecting to obtain pill products. The medicament disclosed by the invention has the effects on nourishing both yin and kidney, cooling blood, dissipating blood stasis, dispelling wind and relieving itching, can be used for treating psoriasis, and has the characteristics of quick effect taking, small side effects and no relapse. Through clinical observation, the effective rate of the medicament is 100%.

Description

A kind ofly be used for the treatment of psoriatic medicine
Technical field
The present invention relates to the psoriatic medicine of a kind of treatment, particularly relating to a kind of is the psoriatic Chinese medicine of treatment of crude drug preparation with Chinese medicine.
Background technology
Psoriasis has another name called psoriasis, is a kind of common erythema unicorn bits property chronic inflammatory disease dermatoses.Psoriasis shows effect repeatedly, and its skin lesion can general whole body, is more common in head, extremity are stretched face, the back, and skin lesion shows as the pale red maculopapule, with the normal skin clear-cut margin, surface coverage has silvery white squama, scrapes off squama, can expose semi-transparent film, scrape off the visible little petechia of this film, illing skin has pruritus in various degree, and men and women, old and young all can fall ill, and is a kind of skin class difficult miscellaneous diseases.At present, clinically this sick Therapeutic Method is adopted external medication mostly, as glucocorticoid, tretinoin cream etc., but side effect is big, can not effect a radical cure, easily repeatedly.
Summary of the invention
The purpose of this invention is to provide a kind of psoriatic medicine that is used for the treatment of, this medicine is made up of Chinese medicine and is had enriching yin and nourishing kidney, cooling blood and removing stasis, and wind dispelling itching relieving effect can play instant effect to psoriatic treatment, and side effect is little, is difficult for the purpose of recurrence.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Radix Rehmanniae 9~11 Radix Angelicae Sinensis 4~6
Rhizoma Chuanxiong 4~6 Radix Paeoniae Albas 4~6
Flos Lonicerae 4~6 Radix Paeoniae Rubra 4~6
Flos Carthami 4~6 Semen Persicaes 4~6
Periostracum Cicadae 4~6 Radix Sophorae Flavescentiss 4~6
Favus skin 4~6 Radix Isatidis 4~6
Herba Spirodelae 4~6 Flos Sophoraes 4~6
Cornu Bubali 5~7 Carapax Trionycis 5~7
Carapax et Plastrum Testudinis 5~7 Agkistrodons 1~3
Zaocys 5~7.
Said medicine can be made any dosage form on the pharmaceutics, as tablet, pill, powder, capsule etc., the preferred dosage form of the present invention is a pill.
The concrete preparation method of medicine of the present invention being made pill is:
Said medicine by described parts by weight mix homogeneously, is ground into 100~120 purpose medicated powder, adds sweet molding, molding according to conventional method medicated powder, sterilization makes the pill product.
The traditional Chinese medical science is thought psoriatic pathogenesis at blood, and endogenous cause of ill mostly is damaged by excess of seven emotions, or eating and drinking without temperance, have a liking for food delicious food savoury etc., so that aquatic weeds heat is in blood; Exopathogenic factor mostly is to experience ailment said due to cold or exposure or hold under the arm and scorchingly injures skin and fall ill.The Therapeutic Principle is enriching yin and nourishing kidney, cooling blood and removing stasis, and wind dispelling is antipruritic.Radix Rehmanniae, Radix Angelicae Sinensis nourishing YIN and supplementing blood; Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver; Rhizoma Chuanxiong blood circulation promoting and blood stasis dispelling, wind-expelling pain-stopping; The Radix Sophorae Flavescentis heat clearing and damp drying; Favus skin heat clearing and damp drying, the detoxifcation of dispeling the wind; Radix Isatidis, Herba Spirodelae heat-clearing and toxic substances removing; The heat clearing away sophora removing heat from blood; The Periostracum Cicadae wind heat extraction that looses; Radix Paeoniae Rubra clearing away heat and cooling blood, eliminating stasis to stop pain; Cornu Bubali clearing away heat and cooling blood, detoxifcation; Semen Persicae, Flos Carthami blood circulation promoting and blood stasis dispelling; Carapax Trionycis, Carapax et Plastrum Testudinis nourishing YIN and clearing away heat; Agkistrodon, Zaocys wind dispelling collateral dredging, expelling pathogenic factors from the exterior are antipruritic.All medicines share, enriching yin and nourishing kidney, and cooling blood and removing stasis, wind dispelling is antipruritic, is used for psoriatic treatment, has instant effect, little, the difficult characteristics that recur of side effect.
For further investigating the clinical efficacy and the safety of medicine of the present invention, select 94 routine psoriatics that the curative effect of medicine of the present invention has been carried out clinical observation.
94 routine cases are divided into two groups at random, and 64 people are organized in treatment, matched group 30 people.All case is diagnosed as psoriasis all according to the diagnostic criteria of " new Chinese medicine clinical research guideline (the 3rd volume) ".
Therapeutic Method
Matched group adopts fangfeng tongsheng pill (big honeyed pills), takes each 1 ball every day 2 times; The noxious dampness clearing capsule is taken 3 every day, one time 3.The treatment group adopts the pill of medicine of the present invention to treat, and takes each 1 ball every day 3 times.40 days is a course of treatment, takes 2 courses of treatment altogether.
Criterion of therapeutical effect
Criterion of therapeutical effect is with reference to " new Chinese medicine clinical research guideline (the 3rd volume) ", and recovery from illness: skin lesion all disappears, or only residual several unconspicuous fritter skin lesion.Effectively: skin lesion disappears more than 30%.Invalid: skin lesion disappears below 30%, or skin lesion no change or skin lesion increase the weight of.
Two groups of case treatment back curative effect comparative results see Table 1.
Table 1 liang group case treatment back curative effect relatively
Group The example number Recovery from illness n(%) Effective n(%) Invalid n(%) Total effective rate n(%)
Matched group 30 21(70) 6(20) 3(10) 27(90)
The treatment group 64 56(87.5) 8(12.5) 0(0) 64(100)
Statistical result showed, treatment group curative effect obviously is better than matched group, and two group differences are remarkable, P<0.05.
The specific embodiment
Embodiment 1
Get Radix Rehmanniae 100g selected, that clear water is cleaned, Radix Angelicae Sinensis 50g, Rhizoma Chuanxiong 50g, Radix Paeoniae Alba 50g, Flos Lonicerae 50g, Radix Paeoniae Rubra 50g, Flos Carthami 50g, Semen Persicae 50g, Periostracum Cicadae 50g, Radix Sophorae Flavescentis 50g, favus skin 50g, Radix Isatidis 50g, Herba Spirodelae 50g, Flos Sophorae 50g, Cornu Bubali 60g Carapax Trionycis 60g, Carapax et Plastrum Testudinis 60g, Agkistrodon 15g, Zaocys 60g mix homogeneously, be ground into 100~120 purpose medicated powder, medicated powder adds sweet molding, molding, and sterilization makes the pill product.
Embodiment 2
Get the Radix Rehmanniae selected, that clear water is cleaned 90 grams, Radix Angelicae Sinensis 45g, Rhizoma Chuanxiong 50g, Radix Paeoniae Alba 55g, Flos Lonicerae 40g, Radix Paeoniae Rubra 50g, Flos Carthami 50g, Semen Persicae 60g, Periostracum Cicadae 50g, Radix Sophorae Flavescentis 50g, favus skin 50g, Radix Isatidis 45g, Herba Spirodelae 50g, Flos Sophorae 50g, Cornu Bubali 55g, Carapax Trionycis 60g, Carapax et Plastrum Testudinis 50g, Agkistrodon 15g, Zaocys 50g mix homogeneously, be ground into 100~120 purpose medicated powder, medicated powder adds sweet molding, molding, and sterilization makes the pill product.

Claims (2)

1. one kind is used for the treatment of psoriatic medicine, is that the Chinese medicine by following portions by weight is that crude drug prepares:
Radix Rehmanniae 9~11 Radix Angelicae Sinensis 4~6
Rhizoma Chuanxiong 4~6 Radix Paeoniae Albas 4~6
Flos Lonicerae 4~6 Radix Paeoniae Rubra 4~6
Flos Carthami 4~6 Semen Persicaes 4~6
Periostracum Cicadae 4~6 Radix Sophorae Flavescentiss 4~6
Favus skin 4~6 Radix Isatidis 4~6
Herba Spirodelae 4~6 Flos Sophoraes 4~6
Cornu Bubali 5~7 Carapax Trionycis 5~7
Carapax et Plastrum Testudinis 5~7 Agkistrodons 1~3
Zaocys 5~7.
2. according to claim 1ly be used for the treatment of psoriatic medicine, it is characterized in that described medicine is made pill.
CN2011100434628A 2011-02-23 2011-02-23 Medicament for treating psoriasis Expired - Fee Related CN102106937B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011100434628A CN102106937B (en) 2011-02-23 2011-02-23 Medicament for treating psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011100434628A CN102106937B (en) 2011-02-23 2011-02-23 Medicament for treating psoriasis

Publications (2)

Publication Number Publication Date
CN102106937A true CN102106937A (en) 2011-06-29
CN102106937B CN102106937B (en) 2012-01-11

Family

ID=44171293

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011100434628A Expired - Fee Related CN102106937B (en) 2011-02-23 2011-02-23 Medicament for treating psoriasis

Country Status (1)

Country Link
CN (1) CN102106937B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103251859A (en) * 2013-03-08 2013-08-21 崔树华 Pharmaceutical composition for treating dermatopathy
CN103251860A (en) * 2013-03-08 2013-08-21 翁捷 Pharmaceutical composition for treating dermatopathy and preparation method
CN103341145A (en) * 2013-07-16 2013-10-09 马庆兵 Traditional Chinese medicine for treating psoriasis and preparation method thereof
CN104027672A (en) * 2014-07-06 2014-09-10 华菊 Traditional Chinese medicine composition for treating psoriasis
CN104127852A (en) * 2014-08-17 2014-11-05 卞永兴 Traditional Chinese medicine for treating psoriasis vulgaris
CN104352626A (en) * 2014-10-13 2015-02-18 洛阳御平国生物科技有限公司 Traditional Chinese medicine formula for treating psoriasis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1682991A (en) * 2005-02-23 2005-10-19 广东怡康制药有限公司 Chinese medicine composition for treating dermatosis and its preparing method
CN1772100A (en) * 2005-10-26 2006-05-17 邢继华 Medicine for treating psoriasis and its prepn
CN1840117A (en) * 2006-01-26 2006-10-04 葛强 Dermatosis-treating medicine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1682991A (en) * 2005-02-23 2005-10-19 广东怡康制药有限公司 Chinese medicine composition for treating dermatosis and its preparing method
CN1772100A (en) * 2005-10-26 2006-05-17 邢继华 Medicine for treating psoriasis and its prepn
CN1840117A (en) * 2006-01-26 2006-10-04 葛强 Dermatosis-treating medicine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
《北京中医》 20060430 黄敏 《寻常型银屑病中医临床与实验研究概况》 第249-251页 1-2 第25卷, 第4期 2 *
《江西中医药》 19921231 于艳丽 《中医药治疗银屑病进展》 第57-58 1-2 第23卷, 第8期 2 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103251859A (en) * 2013-03-08 2013-08-21 崔树华 Pharmaceutical composition for treating dermatopathy
CN103251860A (en) * 2013-03-08 2013-08-21 翁捷 Pharmaceutical composition for treating dermatopathy and preparation method
CN103251859B (en) * 2013-03-08 2015-09-23 崔树华 One treats dermopathic pharmaceutical composition
CN103251860B (en) * 2013-03-08 2015-09-23 翁捷 One treats dermopathic pharmaceutical composition and preparation method thereof
CN103341145A (en) * 2013-07-16 2013-10-09 马庆兵 Traditional Chinese medicine for treating psoriasis and preparation method thereof
CN103341145B (en) * 2013-07-16 2015-04-29 马庆兵 Traditional Chinese medicine for treating psoriasis and preparation method thereof
CN104027672A (en) * 2014-07-06 2014-09-10 华菊 Traditional Chinese medicine composition for treating psoriasis
CN104127852A (en) * 2014-08-17 2014-11-05 卞永兴 Traditional Chinese medicine for treating psoriasis vulgaris
CN104352626A (en) * 2014-10-13 2015-02-18 洛阳御平国生物科技有限公司 Traditional Chinese medicine formula for treating psoriasis

Also Published As

Publication number Publication date
CN102106937B (en) 2012-01-11

Similar Documents

Publication Publication Date Title
CN102106937B (en) Medicament for treating psoriasis
CN104474076A (en) Traditional Chinese medicine composition for treating eczema
CN102247581B (en) Medicament for treating myoma of uterus
CN101703684B (en) Medicament for treating allergic purpura and preparation method thereof
CN103735927B (en) A kind of Chinese medicine composition for the treatment of acute stage of gout and preparation method thereof
CN103961544A (en) Medicine for treating breast diseases
CN103393999A (en) Anti-inflammatory resolutive liquid medicine for promoting blood circulation to arrest pain
CN103736017A (en) Traditional Chinese medicine composition for treating intercostal neuralgia and preparation method of traditional Chinese medicine composition
CN101112552A (en) Dermatosis treating medicine and method for preparing the same
CN104107335A (en) Traditional Chinese medicine composition for oral administration and external application for treating canker sore
CN104491459A (en) Traditional Chinese medicine composition for treating tumors
CN104069355A (en) Medicinal composition for treating rheumatic arthritis and rheumatoid arthritis
CN102670833A (en) Mulberry twig and rehmannia root Chinese medicinal oral solution for relieving rheumatoid arthritis and preparation method of mulberry twig and rehmannia root Chinese medicinal oral solution
CN105194227A (en) Traditional Chinese medicine pills for treating leucoderma and preparation method of traditional Chinese medicine pills
CN105521332A (en) Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof
CN104800772A (en) Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition
CN110478416A (en) The composition and its preparation method and application for treating rheumatic rheumatoid arthritis
CN104248677A (en) Traditional Chinese medicinal preparation for treating erythema multiforme
CN104027719A (en) Traditional Chinese medicine compound composition capable of treating hypersplenism liver-depression and spleen-deficiency type diseases caused by infectious endocarditis and preparation method thereof
CN104027741B (en) A kind of oral medication women Chondromalacia of patella Chinese medicine composition
CN102274336B (en) Medicine composition for treating rheumatoid arthritis
CN102225154B (en) Medicament composition for treating pulmonary fibrosis
CN102335304B (en) Chinese medicine composition for dispelling wind, removing dampness, invigorating blood circulation, and relieving pain and preparation method thereof
CN1277559C (en) Medicine for treating rheumatism and its preparation
CN104208588A (en) Traditional Chinese medicine preparation for treating tumor diseases and preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120111

Termination date: 20130223